miR-22 promotes HBV related hepatocellular carcinoma development in males
Posted in the Oncology Forum
#1 Jul 14, 2011
This study reported in the journal, Clinical Cancer Research, has shown that overexpression of miR-22 relates to the high incidence of HBV-associated hepatocellular carcinoma (HCC) in the male population. News link: http://www.sciclips.com/sciclips/biomarker-ne...
Add your comments below
|Myriad Genetics Announces an Assay that Identif...||Nov 24||Purplemouse2||2|
|gREEN tRees Purp haze, Afghani, SOur Diesel nOW...||Oct '16||D_Drank||1|
|Genetic hallmarks of acute lymphoblastic leukem...||Oct '16||Stephany McDowell||1|
|MALAT1 is a driver for metastasis||Oct '16||Kirkits||1|
|Yale Expert Speaks on Metastatic Breast Cancer ...||Oct '16||Stephany McDowell||1|
|Breast cancer diagnosis: When to seek a second ...||Oct '16||Javk||1|
|Identical Twins Diagnosed With Same Rare Cancer...||Sep '16||Stephany McDowell||1|
Find what you want!
Search Oncology Forum Now
Copyright © 2016 Topix LLC